Home / Archives for February 2012

Archive for February, 2012

European Commission approves Esmya® for the pre-operative treatment of uterine fibroids (myomas)
By Irene Tamayo in News, Press Releases on February 27, 2012
Budapest, Hungary – 27 February 2012 – Gedeon Richter Plc. (“Richter”) announces today that the European Commission (EC) has granted…
0
0
Ulipristal acetate versus leuprolide acetate for uterine fibroids
By Irene Tamayo in Publication on February 2, 2012
Authors: Donnez J, Tomaszewski J, Vazquez F, Bouchard P, Lemieszczuk B, Baro F, et al happy new year images
N Engl J Med 2012;366:421–32.
0
PEARL I and II studies published in New England Journal of Medicine confirm the efficacy of Esmya® (ulipristal acetate) for the pre-operative treatment of uterine fibroids (myomas)
By Irene Tamayo in News, Press Releases on February 2, 2012
Geneva, Switzerland – 2 February 2012 – PregLem, the wholly owned subsidiary of Gedeon Richter, announces full results of PEARL…
0
0

Send this to friend

Your emailRecipient email

European Commission approves Esmya® for the pre-operative treatment of uterine fibroids (myomas)